Indaptus Therapeutics, Inc. (INDP)
2.82
-0.31
(-9.90%)
USD |
NASDAQ |
Nov 20, 12:23
Indaptus Therapeutics Cash from Investing (Quarterly) : 0.0882M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0882M |
| June 30, 2026 | -4.103M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.0611M |
| September 30, 2023 | 6.623M |
| June 30, 2023 | 7.837M |
| March 31, 2023 | 2.141M |
| December 31, 2022 | 5.076M |
| September 30, 2022 | -2.704M |
| June 30, 2022 | -15.39M |
| March 31, 2022 | -2.798M |
| December 31, 2021 | 0.4624M |
| September 30, 2021 | -0.0017M |
| June 30, 2021 | -0.0022M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.7676M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0014M |
| March 31, 2020 | 0.769M |
| December 31, 2019 | -0.689M |
| September 30, 2019 | -1.568M |
| June 30, 2019 | -0.3768M |
| March 31, 2019 | -0.64M |
| December 31, 2018 | -4.020M |
| September 30, 2018 | -0.7693M |
| June 30, 2018 | -2.263M |
| March 31, 2018 | -1.976M |
| December 31, 2017 | -2.561M |
| September 30, 2017 | -0.776M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -5.440M |
| September 30, 2015 | -0.0872M |
| June 30, 2015 | -0.2479M |
| March 31, 2015 | -0.6293M |
| December 31, 2014 | -0.1209M |
| September 30, 2014 | 1.730M |
| June 30, 2014 | 1.772M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | -6.00M |
| Capricor Therapeutics, Inc. | 59.90M |
| Ocugen, Inc. | -59.77M |
| Cue Biopharma, Inc. | 0.00 |
| Yarrow Bioscience, Inc. | -5.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.245M |
| Cash from Financing (Quarterly) | 20.30M |
| Free Cash Flow | -13.97M |
| Free Cash Flow Per Share (Quarterly) | -0.0093 |
| Free Cash Flow to Equity (Quarterly) | -1.245M |
| Free Cash Flow to Firm (Quarterly) | -1.245M |
| Free Cash Flow Yield | -3.72% |